MacroGenics Insider Boost: Senior VP Bonvini Exercises $2.60 Options, Holds Shares as Company’s Biologics Pipeline Grows Confidence
MacroGenics insider confidence rises as SVP Bonvini exercises $2.60 options, holding shares near $4.09. Insight into pipeline and future upside.
3 minutes to read